Drugs that target pathogen public goods are robust against evolved drug resistance

Abstract excerpt

Pathogen drug resistance is a central problem in medicine and public health. It arises through somatic evolution, by mutation and selection among pathogen cells within a host. Here, we examine the hypothesis that evolution of drug resistance could be reduced by developing drugs that target the secreted metabolites produced by pathogen cells instead of directly targeting the cells themselves. Using an agent-based...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Evolution and Genetic Dynamics
• Share to Evolutionary Game Theory and Cooperation
• Share to Mathematical and Theoretical Epidemiology and Ecology Models